1 Table of Contents
1.1 List of Tables
1.2 List of Figures
2 Introduction
2.1 What Is This Report About?
2.2 Hematological Disorders Market Segmentation
2.3 Definitions of Markets Covered in the Report
3 Hematological Disorders Market, United States
3.1 Hematological Disorders Market, United States, Revenue ($m), 2018-2033
3.1.1 Hematology Tests Market, United States, Revenue ($m), by Segment, 2018-2033
3.1.2 Hemostasis Tests Market, United States, Revenue ($m), by Segment, 2018-2033
3.2 Hematological Disorders Market, United States, Volume (Units), 2018-2033
3.2.1 Hematology Tests Market, United States, Volume (Units), by Segment, 2018-2033
3.2.2 Hemostasis Tests Market, United States, Volume (Units), by Segment, 2018-2033
3.3 Hematological Disorders Market, United States, Average Price ($) , 2018-2033
3.4 Hematological Disorders Market, United States, Company Share by Revenue ($m), 2024
4 Overview of Key Companies in United States, Hematological Disorders Market
4.1 Abbott Laboratories
4.1.1 Company Overview
4.2 F. Hoffmann-La Roche Ltd
4.2.1 Company Overview
4.3 Sysmex Corp
4.3.1 Company Overview
4.4 Siemens AG
4.4.1 Company Overview
4.5 WerfenLife SA
4.5.1 Company Overview
4.6 Danaher Corp
4.6.1 Company Overview
4.7 Diagnostica Stago SAS
4.7.1 Company Overview
4.8 Quidel Corp
4.8.1 Company Overview
4.9 Thermo Fisher Scientific Inc
4.9.1 Company Overview
4.10 Siemens Healthineers AG
4.10.1 Company Overview
4.11 Horiba Ltd
4.11.1 Company Overview
4.12 EKF Diagnostics Holdings Plc
4.12.1 Company Overview
4.13 Bio-Rad Laboratories Inc
4.13.1 Company Overview
4.14 bioMerieux SA
4.14.1 Company Overview
6 Financial Deals Landscape
6.1 Equity Offerings
6.1.1 CurveBeam AI to Raise USD1.29 Million in Private Placement of Shares
6.1.2 CurveBeam AI (CurveBeamAI) Raises USD1.07 Million in Entitlement Rights Offering of Shares
6.2 Venture Financing
6.2.1 Mendaera Secures USD73 Million in Series B Funding
7 Recent Developments
7.1 Corporate Communications
7.1.1 Oct 16, 2024: PatientPoint CEO Sean Slovenski Shares Vision for Future of Health Care, Creates New Innovation Network Fueled by Partnerships and Appoints Chief Experience and Innovation Officer
7.1.2 Oct 02, 2024: Quanterix Adds Ivana Magovcevic-Liebisch to Board of Directors
7.1.3 Aug 20, 2024: Bio-Rad Appoints Jon DiVincenzo President, Chief Operating Officer
7.1.4 Aug 19, 2024: Jeffrey Elliott Appointed to Quanterix’s Board of Directors
7.2 Government and Public Interest
7.2.1 Jan 02, 2025: Quanterix to Present at the 43rd Annual J.P. Morgan Healthcare Conference
7.2.2 Aug 29, 2024: Quanterix to Participate at the Morgan Stanley 22nd Annual Global Healthcare Conference
7.2.3 Jun 17, 2024: Quanterix to Participate at the Scotiabank Healthcare 1x1 Day
7.3 Other Significant Developments
7.3.1 Jan 13, 2025: Rigel Provides Business Update and 2025 Outlook
7.3.2 Jan 10, 2025: Quanterix To Acquire Akoya Biosciences, Creating the First Integrated Solution for Ultra-Sensitive Detection of Blood- And Tissue-Based Protein Biomarkers
7.4 Product News
7.4.1 Mar 18, 2025: Bionano Announces Extensive Lineup of Content at American College of Medical Genetics and Genomics (ACMG) 2025 Annual Meeting
7.4.2 Feb 04, 2025: Blood Test Eases Diagnosis of Invasive Mold Disease
7.4.3 Feb 03, 2025: At SCOPE 2025, ConcertAI Announces Major Advances in Trial Technologies for Research Sites and Sponsors
7.4.4 Sep 17, 2024: The Results Of a Test Created In Barcelona For The Detection Of Multiple Cancers Are Presented at ESMO
8 Appendix
8.1 Research Methodology
8.1.1 Coverage
8.1.2 Secondary Research
8.1.3 Primary Research
8.1.4 Market Modeling and Forecasting
8.1.5 Company Share Analysis
8.1.6 Benchmarking
8.2 the analyst Consulting
8.3 Contact the Publisher
8.4 Disclaimer
List of Tables
Table 1: Hematological Disorders Market, United States, Revenue ($m), USD Constant, 2018-2033
Table 2: Hematology Tests Market, United States, Revenue ($m), USD Constant, 2018-2033
Table 3: Hemostasis Tests Market, United States, Revenue ($m), USD Constant, 2018-2033
Table 4: Hematological Disorders Market, United States, Volume (Units), 2018-2033
Table 5: Hematology Tests Market, United States, Volume (Units), 2018-2033
Table 6: Hemostasis Tests Market, United States, Volume (Units), 2018-2033
Table 7: Hematological Disorders Market, United States, Average Price ($), 2018-2033
Table 8: Hematological Disorders Market, United States, Company Share by Revenue ($m), 2024
Table 9: Hematological Disorders Market Pipeline Products
Table 10: CurveBeam AI to Raise USD1.29 Million in Private Placement of Shares
Table 11: CurveBeam AI (CurveBeamAI) Raises USD1.07 Million in Entitlement Rights Offering of Shares
Table 13: Total Number of Primary Research Participants, In Vitro Diagnostics Market, by Country
List of Figures
Figure 1: Hematological Disorders Market, United States, Revenue ($m), USD Constant, 2018-2033
Figure 2: Hematology Tests Market, United States, Revenue ($m), USD Constant, 2018-2033
Figure 3: Hemostasis Tests Market, United States, Revenue ($m), USD Constant, 2018-2033
Figure 4: Hematological Disorders Market, United States, Volume (Units), 2018-2033
Figure 5: Hematology Tests Market, United States, Volume (Units), 2018-2033
Figure 6: Hemostasis Tests Market, United States, Volume (Units), 2018-2033
Figure 7: Hematological Disorders Market, United States, Company Share (%), 2024
